|
GRB2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.30482299912182E-13 |
| Normal-vs-Stage2 |
6.18030000000269E-05 |
| Normal-vs-Stage3 |
3.206500E-04 |
| Normal-vs-Stage4 |
6.288000E-02 |
| Stage1-vs-Stage2 |
6.377000E-01 |
| Stage1-vs-Stage3 |
8.956400E-01 |
| Stage1-vs-Stage4 |
8.078800E-01 |
| Stage2-vs-Stage3 |
5.943600E-01 |
| Stage2-vs-Stage4 |
5.786800E-01 |
| Stage3-vs-Stage4 |
8.850600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
3.50220000000512E-07 |
| Normal-vs-Asian |
1.365780E-01 |
| Caucasian-vs-AfricanAmerican |
2.535800E-01 |
| Caucasian-vs-Asian |
7.159400E-01 |
| AfricanAmerican-vs-Asian |
4.530200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62436730732907E-12 |
| Normal-vs-Female |
1.58909552183673E-11 |
| Male-vs-Female |
6.080800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.565590E-04 |
| Normal-vs-Extreme_Weight |
2.21870000149949E-09 |
| Normal-vs-Obese |
1.08639996998505E-09 |
| Normal-vs-Extreme_Obese |
3.464000E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.235600E-01 |
| Normal_Weight-vs-Obese |
2.311000E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.256400E-01 |
| Extreme_Weight-vs-Obese |
8.555400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.589200E-01 |
| Obese-vs-Extreme_Obese |
3.852400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.89559999999434E-05 |
| Normal-vs-Age(41-60Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(61-80Yrs) |
6.95032920106087E-12 |
| Normal-vs-Age(81-100Yrs) |
3.434000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.953000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.802300E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.208390E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.656800E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.725800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.490200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
<1E-12 |
| Normal-VS-Type2 PRCC |
2.99840000050899E-07 |
| Normal-VS-KIRP CIMP |
8.077700E-02 |
| Normal-VS-Unclassified PRCC |
7.46630000048043E-07 |
| Type1 PRCC-VS-Type2 PRCC |
1.448340E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.949800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.445400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.820000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.353600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.408600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.66949999952971E-07 |
| Normal-vs-N1 |
3.381500E-04 |
| Normal-vs-N2 |
1.817160E-01 |
| N0-vs-N1 |
6.325600E-01 |
| N0-vs-N2 |
4.234400E-01 |
| N1-vs-N2 |
2.622800E-01 |
|
|
